{"id":"https://openalex.org/W4403554675","doi":"https://doi.org/10.1016/j.htct.2024.09.1155","title":"REVOLUTIONIZING POST-TRANSPLANT CARE IN PEDIATRIC ACUTE MYELOID LEUKEMIA (AML) WITH TAILORED MAINTENANCE THERAPIES: A LEAP TOWARDS ENHANCED SURVIVAL AGAINST ACTIVE DISEASE","display_name":"REVOLUTIONIZING POST-TRANSPLANT CARE IN PEDIATRIC ACUTE MYELOID LEUKEMIA (AML) WITH TAILORED MAINTENANCE THERAPIES: A LEAP TOWARDS ENHANCED SURVIVAL AGAINST ACTIVE DISEASE","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403554675","doi":"https://doi.org/10.1016/j.htct.2024.09.1155"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2024.09.1155","doi":"https://doi.org/10.1016/j.htct.2024.09.1155","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.1155","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4403554675"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1016/j.htct.2024.09.1155","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023907554","display_name":"Carla Nolasco Monteiro Breviglieri","orcid":"https://orcid.org/0000-0002-6089-5526","observed_orcids":["https://orcid.org/0000-0002-6089-5526"]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"CNM Breviglieri","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109500826","display_name":"RG Vasconcelos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"RG Vasconcelos","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100861356","display_name":"CN Santos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"CN Santos","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032713688","display_name":"VC Ginani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"VC Ginani","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":null,"display_name":"MRS Oliveira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"MRS Oliveira","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":null,"display_name":"ABW Batalha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"ABW Batalha","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014147073","display_name":"JF Marques","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"JF Marques","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"middle","author":{"id":null,"display_name":"GS Alencar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"GS Alencar","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055586226","display_name":"Adriana Seber","orcid":"https://orcid.org/0000-0003-4578-9423","observed_orcids":["https://orcid.org/0000-0003-4578-9423"]},"institutions":[{"id":"https://openalex.org/I4210097205","display_name":"Hospital Samaritano de S\u00e3o Paulo","ror":"https://ror.org/00var7h03","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210097205"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"A Seber","raw_affiliation_strings":["Hospital Samaritano, S\u00e3o Paulo, SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Samaritano, S\u00e3o Paulo, SP, Brazil","institution_ids":["https://openalex.org/I4210097205"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210097205"],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"46","issue":null,"first_page":"S688","last_page":"S688"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.05530000105500221,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pediatric-acute-myeloid-leukemia","display_name":"pediatric acute myeloid leukemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/post-transplant-maintenance-therapy","display_name":"post-transplant maintenance therapy","score":0.9679999947547913},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.671999990940094},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.8309999704360962},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.8460000157356262},{"id":"https://openalex.org/keywords/flt3-inhibitors","display_name":"FLT3 inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8690000176429749},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.7039999961853027},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5759999752044678},{"id":"https://openalex.org/keywords/graft-function","display_name":"graft function","score":0.4650000035762787},{"id":"https://openalex.org/keywords/haploidentical-transplantation","display_name":"haploidentical transplantation","score":0.7059999704360962},{"id":"https://openalex.org/keywords/busulfan-conditioning","display_name":"busulfan conditioning","score":0.6439999938011169},{"id":"https://openalex.org/keywords/myeloablative-conditioning","display_name":"myeloablative conditioning","score":0.7369999885559082},{"id":"https://openalex.org/keywords/transplant-related-toxicity","display_name":"transplant toxicity","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.96214359998703},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.806004524230957},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6040992736816406},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5239827036857605},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4833337962627411},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4692646861076355},{"id":"https://openalex.org/C2993296363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukaemia","level":2,"score":0.42743241786956787},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32769161462783813}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2024.09.1155","doi":"https://doi.org/10.1016/j.htct.2024.09.1155","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.1155","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:e55c74ee82c8490bb7e7420f999c4f65","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e55c74ee82c8490bb7e7420f999c4f65","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S688- (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2024.09.1155","doi":"https://doi.org/10.1016/j.htct.2024.09.1155","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2024.09.1155","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4399054905","https://openalex.org/W4403554681","https://openalex.org/W4386270732","https://openalex.org/W4377221156","https://openalex.org/W4310102642","https://openalex.org/W4285092566","https://openalex.org/W4310103289","https://openalex.org/W4408158935","https://openalex.org/W3119843276","https://openalex.org/W7165396927"],"abstract_inverted_index":{"Pediatric":[0],"Acute":[1],"Myeloid":[2],"Leukemia":[3],"(AML)":[4],"presents":[5],"significant":[6],"treatment":[7,128,390],"challenges,":[8],"particularly":[9,75],"post-transplant":[10,33,68,197,346],"relapses.":[11],"The":[12,53,148,301],"use":[13],"of":[14,31,55,65,92,144,151,173,186,219,224,367,374],"the":[15,27,61,66,142,174,184,230,257,365,372],"only":[16,193],"specific":[17],"immunotherapy":[18],"for":[19,39,46,310,328,350,389],"AML":[20,95],"may":[21],"increase":[22],"transplant-related":[23],"toxicities":[24],"due":[25,189,360],"to":[26,42,59,83,140,190,322,361,378,401],"calicheamicin.":[28],"This":[29],"scarcity":[30],"effective":[32],"strategies":[34],"underscores":[35],"a":[36,201,217,222,271,386,393],"critical":[37],"need":[38],"innovative":[40],"approaches":[41],"improve":[43],"survival,":[44,303,305],"especially":[45],"those":[47,76,266,329,355],"undergoing":[48],"transplantation":[49,79],"with":[50,80,111,178,207,221,234,260,352,356],"active":[51,81,112,261,362],"disease.":[52],"objective":[54],"his":[56],"study":[57],"is":[58,399],"describe":[60],"experience":[62],"and":[63,86,100,120,130,137,163,209,242,252,306,318,325,335,381,405],"effectiveness":[64],"tailored":[67,375],"maintenance":[69,145,198,241,251,269,283,313,344,376],"therapy":[70,314,345],"used":[71],"in":[72,205,254,298,392],"pediatric":[73,94],"AML,":[74,353],"who":[77,267,281,311,330],"entered":[78],"disease,":[82,113],"enhance":[84],"survival":[85,135,380],"cure":[87],"rates.":[88],"Methods:":[89],"Retrospective":[90],"analysis":[91],"30":[93,187],"patients":[96,109,232,249,259],"transplanted":[97,110,233],"between":[98],"2014":[99],"2024.":[101],"From":[102],"2021":[103],"on,":[104],"high":[105],"risk":[106],"or":[107,116,263,288],"FLT3-ITD+":[108],"received":[114,196,250,268,282,312],"azacytidine":[115],"decitabine,":[117],"FLT3":[118,211],"inhibitors":[119],"venetoclax.":[121],"We":[122],"collected":[123],"demographic":[124],"data,":[125],"disease":[126,262,363],"characteristics,":[127],"regimens,":[129],"clinical":[131],"outcomes,":[132],"using":[133],"Kaplan-Meier":[134],"estimates":[136],"log-rank":[138],"test":[139],"assess":[141],"impact":[143],"therapy.":[146],"Results:":[147],"median":[149,218,307],"age":[150],"participants":[152],"was":[153,214,292],"4":[154],"years,":[155],"63%":[156],"male.":[157],"Most":[158],"conditioning":[159],"regimens":[160],"were":[161,168,176,315],"myeloablative":[162],"busulfan-based":[164],"(63%).":[165],"Twenty":[166],"transplants":[167,175],"haploidentical":[169],"(67%).":[170],"Notably,":[171],"53%":[172],"performed":[177],">":[179],"5%":[180],"marrow":[181],"blasts.":[182],"Among":[183],"total":[185],"transplants,":[188],"insurance":[191],"restraints,":[192],"8":[194],"(27%)":[195],"therapy:":[199],"7":[200],"hypomethylating":[202],"agent,":[203],"5":[204,225],"combination":[206],"venetoclax":[208],"2":[210],"inhibitors.":[212],"Maintenance":[213],"started":[215],"at":[216,364],"D+59":[220],"duration":[223],"months":[226,327],"(1-18":[227],"months).":[228],"Of":[229,256],"11":[231],"negative":[235,248],"MRD,":[236,265],"9":[237],"did":[238,331],"not":[239,332],"receive":[240],"3":[243],"relapsed":[244],"(33%).":[245],"Two":[246],"MRD":[247],"remain":[253],"remission.":[255],"19":[258],"positive":[264],"had":[270],"much":[272],"lower":[273],"relapse":[274,383],"rate":[275],"(17%":[276],"vs.":[277],"46%).":[278],"No":[279],"patient":[280,395],"developed":[284],"poor":[285],"graft":[286,289],"function":[287],"failure.":[290],"There":[291],"no":[293],"mortality":[294],"from":[295],"infectious":[296],"causes":[297],"this":[299],"group.":[300],"overall":[302],"relapse-free":[304],"follow-up":[308],"time":[309,366],"86%,":[316],"86%":[317],"26":[319],"months,":[320],"compared":[321],"25%,":[323],"19%":[324],"42":[326],"(p":[333],"0.02":[334],"p":[336],"0.01":[337],"respectively).":[338],"Conclusion:":[339],"Preliminary":[340],"results":[341],"suggest":[342],"that":[343],"significantly":[347],"enhances":[348],"outcomes":[349],"children":[351],"even":[354],"traditionally":[357],"poorer":[358],"prognoses":[359],"transplant.":[368],"These":[369],"findings":[370,404],"highlight":[371],"potential":[373],"therapies":[377],"extend":[379],"reduce":[382],"rates,":[384],"providing":[385],"new":[387],"avenue":[388],"protocols":[391],"challenging":[394],"subset.":[396],"Further":[397],"research":[398],"warranted":[400],"confirm":[402],"these":[403],"potentially":[406],"guide":[407],"practice.":[408]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2024-10-19T00:00:00"}